DISEASE SUSCEPTIBILITY GENES IN PEDIATRIC ANTIPHOSPHOLIPID ANTIBODY SYNDROME
DISEASE SUSCEPTIBILITY GENES IN PEDIATRIC ANTIPHOSPHOLIPID ANTIBODY SYNDROME
批准号:
6235673
负责人:
EMILY VON SCHEVEN
金额:
$9.33万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-01 至 1997-12-31
中文摘要
抗磷脂抗体综合征(APS)是一种血栓性疾病
以血栓形成与定向抗体相关为特征的
对抗磷脂。除了蛋白C,S蛋白还有抗凝血酶
III缺乏症和因子V莱顿突变,APS构成
儿童血栓形成的重要原因通常没有被认识到
由儿科医生提供。APS既作为一种继发性疾病存在于
与系统性红斑狼疮(SLE)相关,并作为原发病
没有潜在风湿性疾病的综合症。
抗磷脂抗体(APL)是异质性的,可以
用几种不同的化验方法检测。虽然这一综合征
近年来在文学上受到越来越多的关注,有
关于抗体检测、抗原性仍有许多悬而未决的问题
目标、诊断、发病机制和适当的临床处理。
此外,还有关于诊断、预后、
以及儿科人群的管理。二级专业
组织复制复合体(MHC)基因编码相关分子
随着对自我和非我的区分,抗原的呈递
免疫激活和调节T细胞识别。第II类
此前,MHC基因与疾病易感性相关
几种风湿性和非风湿性疾病
调查人员。有证据表明,第二类MHC协会可能
APL的表达和APS的后续发展存在于
成人,但尚未在儿童中广泛研究。不是全部
循环中的急性早幼粒细胞白血病患者随后会发展为急性胰腺炎。和
最近,β2-糖蛋白I已被证明是重要的
在检测确实有血栓形成的个体的APL时。
证据支持第五结构域的磷脂结合作用,以及
因此,该区域的多态性可能与APS有关。这个
该项目的目的是识别疾病易感基因,
可能是一组儿童的特征,他们有更高的
血栓形成的发展,并可能导致
了解这种疾病的发病机制。
英文摘要
Antiphospholipid antibody syndrome (APS) is a thrombotic disorder
characterized by the association of thrombosis with antibodies directed
against phospholipids. In addition to protein C, protein S, antithrombin
III deficiency, and Factor V Leiden mutation, APS constitutes a
significant cause of thrombosis in children that is often no recognized
by pediatricians. APS exists both as a secondary disorder in
association with systemic lupus erythematosus (SLE), and as a primary
syndrome in the absence of underlying rheumatic disorders.
Antiphospholipid antibodies (aPL) are heterogeneous and can be
detected by several different assays. Although the syndrome has
received increased attention in the literature in recent years, there are
still many unanswered questions regarding antibody detection, antigenic
target, diagnosis, pathogenesis, and appropriate clinical management.
Furthermore, there are unique issues regarding diagnosis, prognosis,
and management in the pediatric population. Class II Major
Histocopatibility Complex (MHC) genes encode molecules involved
with the discrimination of self and non-self, presentation of antigen for
immuneactivation, and modulation of T cell recognition. Class II
MHC genes have previously been correlated with disease susceptibility
for several rheumatic and non-rheumatic disorders by other
investigators. Evidence suggests that Class II MHC associations may
exist for the expression of aPL and subsequent development of APS in
adults, and has not been studied extensively in children. Not all
individuals with circulating aPL subsequently develop APS. And
recently, Beta 2-Glycoprotein I has been demonstrated to be important
in the detection of aPL from individuals who do develop thromboses.
Evidence supports a phospholipid binding role for the fifth domain, and
thus polymorphism of this region may be associated with APS. The
purpose of this project is to identify disease susceptibility genes which
may characterize a subgroup of children at increased risk for the
development of thrombosis, and potentially contribute to an increased
understanding of the pathogenesis of this disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LONG TERM OUTCOME OF CHILDREN AND ADOLESCENTS WITH APL
-
批准号:7204853
-
项目类别:
-
资助金额:$9.21万
-
财政年份:2005
-
负责人:EMILY VON SCHEVEN
-
依托单位:
BONE MINERAL DENSITY OF CHILDREN AND ADOLESCENTS WITH SLE
-
批准号:7204857
-
项目类别:
-
资助金额:$1.54万
-
财政年份:2005
-
负责人:EMILY VON SCHEVEN
-
依托单位:
BONE MINERAL DENSITY STUDY IN SLE
-
批准号:7204836
-
项目类别:
-
资助金额:$6.9万
-
财政年份:2005
-
负责人:EMILY VON SCHEVEN
-
依托单位:
ALENDRONATE FOR THE TREATMENT OF CHILDHOOD OSTEOPENIA AND OSTEOPOROSIS
-
批准号:7204862
-
项目类别:
-
资助金额:$6.24万
-
财政年份:2005
-
负责人:EMILY VON SCHEVEN
-
依托单位:
THE ATHEROSCLEROSIS PREVENTION IN PEDIATRIC LUPUS ERYTHEMATOSUS (APPLE) STUDY
-
批准号:7204888
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2005
-
负责人:EMILY VON SCHEVEN
-
依托单位:
MUTATIONS IN T AND B-CELL SIGNALING PROTEINS IN CHILDREN WITH AUTOIMMUNE DISEASE
-
批准号:7204854
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2005
-
负责人:EMILY VON SCHEVEN
-
依托单位:
Long term outcome of children and adolescents with APL
-
批准号:7043555
-
项目类别:
-
资助金额:$4.44万
-
财政年份:2004
-
负责人:EMILY VON SCHEVEN
-
依托单位:
Bone mineral density study in SLE
-
批准号:7043534
-
项目类别:
-
资助金额:$5.28万
-
财政年份:2004
-
负责人:EMILY VON SCHEVEN
-
依托单位:
Bone mineral density of children and adolescents with SLE
-
批准号:7043560
-
项目类别:
-
资助金额:$1.15万
-
财政年份:2004
-
负责人:EMILY VON SCHEVEN
-
依托单位:
Alendronate for the treatment of childhood osteopenia and osteoporosis
-
批准号:7043568
-
项目类别:
-
资助金额:$3.93万
-
财政年份:2004
-
负责人:EMILY VON SCHEVEN
-
依托单位:
BONE MINERAL DENSITY IN SYSTEMIC LUPUS ERTHEMATOSUS IN CHILDREN
-
批准号:6563615
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2002
-
负责人:EMILY VON SCHEVEN
-
依托单位:
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
-
批准号:6916285
-
项目类别:
-
资助金额:$15.28万
-
财政年份:2001
-
负责人:EMILY VON SCHEVEN
-
依托单位:
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
-
批准号:6541988
-
项目类别:
-
资助金额:$12.78万
-
财政年份:2001
-
负责人:EMILY VON SCHEVEN
-
依托单位:
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
-
批准号:6650217
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2001
-
负责人:EMILY VON SCHEVEN
-
依托单位:
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
-
批准号:6368339
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2001
-
负责人:EMILY VON SCHEVEN
-
依托单位:
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT
-
批准号:6786785
-
项目类别:
-
资助金额:$14.3万
-
财政年份:2001
-
负责人:EMILY VON SCHEVEN
-
依托单位:
BONE MINERAL DENSITY IN SYSTEMIC LUPUS ERTHEMATOSUS IN CHILDREN
-
批准号:6299798
-
项目类别:
-
资助金额:$14.6万
-
财政年份:2000
-
负责人:EMILY VON SCHEVEN
-
依托单位:
MAJOR HISTOCOMPATIBILITY COMPLEX ASSOCIATIONS WITH ANTIPHOSPHOLIPID ANTIBODIES
-
批准号:6308631
-
项目类别:
-
资助金额:$2.58万
-
财政年份:1999
-
负责人:EMILY VON SCHEVEN
-
依托单位:
BONE MINERAL DENSITY IN SYSTEMIC LUPUS ERTHEMATOSUS IN CHILDREN
-
批准号:6100372
-
项目类别:
-
资助金额:$14.6万
-
财政年份:1999
-
负责人:EMILY VON SCHEVEN
-
依托单位:
DISEASE SUSCEPTIBILITY GENES IN PEDIATRIC ANTIPHOSPHOLIPID ANTIBODY SYNDROME
-
批准号:6268318
-
项目类别:
-
资助金额:$9.36万
-
财政年份:1998
-
负责人:EMILY VON SCHEVEN
-
依托单位: